Abbott price target raised to $132 from $125 at Bernstein

Bernstein raised its price target on Abbott to $132 from $125 and keeps an Outperform rating on the shares. The firm believes the stock checks a lot of boxes for investors, including durable long-term growth, diversification and stability, balance sheet firepower, margin upside, and a dividend. Libre 3 ramp is beginning to kick in as an important growth driver, and Bernstein sees good reasons to be involved as additional catalysts play out and as Abbott deploys cash.